Stefanie E Mayer1, Aric A Prather2, Eli Puterman3, Jue Lin4, Justine Arenander2, Michael Coccia2, Grant S Shields5, George M Slavich6, Elissa S Epel2. 1. Department of Psychiatry, University of California, San Francisco, CA, USA. Electronic address: Stefanie.Mayer@ucsf.edu. 2. Department of Psychiatry, University of California, San Francisco, CA, USA. 3. School of Kinesiology, University of British Columbia, Vancouver, BC, Canada. 4. Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA. 5. Center for Neuroscience and Department of Psychology, University of California, Davis, CA, USA. 6. Cousins Center for Psychoneuroimmunology and Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
Abstract
BACKGROUND: Stress exposure occurring across the lifespan increases risk for disease, potentially involving telomere length shortening. Stress exposure during childhood and adulthood has been cross-sectionally linked with shorter telomere length. However, few longitudinal studies have examined telomere length attrition over time, and none have investigated how stressor duration (acute life events vs. chronic difficulties), timing (childhood vs. adulthood), and perceived severity may be uniquely related to telomere length shortening. METHODS: To address these issues, we administered a standardized instrument for assessing cumulative lifetime stress exposure (Stress and Adversity Inventory; STRAIN) to 175 mothers of children with Autism Spectrum Disorder or neurotypical children and measured their leukocyte telomere length (LTL) at baseline and 2 years later. RESULTS: Greater count of lifetime stressors was associated with shorter LTL at baseline and greater LTL attrition over time. When separating lifetime stressors into acute life events and chronic difficulties, only greater count of chronic difficulties significantly predicted shorter baseline LTL and greater LTL attrition. Similarly, when examining timing of stressor exposure, only greater count of chronic childhood difficulties (age < 18) significantly predicted shorter baseline LTL and greater LTL attrition over the 2-year period in mid-life. Importantly, these results were robust while controlling for stressors occurring during the interim 2-year period. Post-hoc analyses suggested that chronic difficulties occurring during earlier childhood (0-12 years) were associated with greater LTL attrition. Cumulative stressor severity predicted LTL attrition in a parallel manner, but was less consistently associated with baseline LTL. CONCLUSIONS: These data are the first to examine the effects of different aspects of cumulative lifetime stress exposure on LTL attrition over time, suggesting that accumulated chronic difficulties during childhood may play a unique role in shaping telomere shortening in midlife.
BACKGROUND:Stress exposure occurring across the lifespan increases risk for disease, potentially involving telomere length shortening. Stress exposure during childhood and adulthood has been cross-sectionally linked with shorter telomere length. However, few longitudinal studies have examined telomere length attrition over time, and none have investigated how stressor duration (acute life events vs. chronic difficulties), timing (childhood vs. adulthood), and perceived severity may be uniquely related to telomere length shortening. METHODS: To address these issues, we administered a standardized instrument for assessing cumulative lifetime stress exposure (Stress and Adversity Inventory; STRAIN) to 175 mothers of children with Autism Spectrum Disorder or neurotypical children and measured their leukocyte telomere length (LTL) at baseline and 2 years later. RESULTS: Greater count of lifetime stressors was associated with shorter LTL at baseline and greater LTL attrition over time. When separating lifetime stressors into acute life events and chronic difficulties, only greater count of chronic difficulties significantly predicted shorter baseline LTL and greater LTL attrition. Similarly, when examining timing of stressor exposure, only greater count of chronic childhood difficulties (age < 18) significantly predicted shorter baseline LTL and greater LTL attrition over the 2-year period in mid-life. Importantly, these results were robust while controlling for stressors occurring during the interim 2-year period. Post-hoc analyses suggested that chronic difficulties occurring during earlier childhood (0-12 years) were associated with greater LTL attrition. Cumulative stressor severity predicted LTL attrition in a parallel manner, but was less consistently associated with baseline LTL. CONCLUSIONS: These data are the first to examine the effects of different aspects of cumulative lifetime stress exposure on LTL attrition over time, suggesting that accumulated chronic difficulties during childhood may play a unique role in shaping telomere shortening in midlife.
Authors: K K Ridout; M Levandowski; S J Ridout; L Gantz; K Goonan; D Palermo; L H Price; A R Tyrka Journal: Mol Psychiatry Date: 2017-03-21 Impact factor: 15.992
Authors: A O'Donovan; J Lin; J Tillie; J M Tillie; F S Dhabhar; O M Wolkowitz; O Wolkowitz; E H Blackburn; E Blackburn; E S Epel; E Epel Journal: Brain Behav Immun Date: 2008-12-11 Impact factor: 7.217
Authors: David H Rehkopf; Belinda L Needham; Jue Lin; Elizabeth H Blackburn; Ami R Zota; Janet M Wojcicki; Elissa S Epel Journal: PLoS Med Date: 2016-11-29 Impact factor: 11.069
Authors: Iulia Banica; Aislinn Sandre; Grant S Shields; George M Slavich; Anna Weinberg Journal: Int J Psychophysiol Date: 2020-04-08 Impact factor: 2.997
Authors: Teresa Smith; Elaina Johns-Wolfe; Grant S Shields; Jennifer Malat; Farrah Jacquez; George M Slavich Journal: Stress Health Date: 2020-03-05 Impact factor: 3.519
Authors: Kimberly G Lockwood; Luke Peddie; Alexandra D Crosswell; Benjamin A Hives; Natalie Slopen; David M Almeida; Eli Puterman Journal: Ann Behav Med Date: 2022-10-03
Authors: Lawson R Wulsin; Sara J Sagui-Henson; Lydia G Roos; Diana Wang; Brooke Jenkins; Beth E Cohen; Amit J Shah; George M Slavich Journal: Psychosom Med Date: 2022-04-01 Impact factor: 4.312
Authors: Sarah C Sturmbauer; Grant S Shields; Eva-Luca Hetzel; Nicolas Rohleder; George M Slavich Journal: PLoS One Date: 2019-05-09 Impact factor: 3.240
Authors: Marta Falcinelli; Premal H Thaker; Susan K Lutgendorf; Suzanne D Conzen; Renée L Flaherty; Melanie S Flint Journal: Cancer Res Date: 2021-07-15 Impact factor: 12.701